Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.62 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.62 |
| ▸ | MEN1 | O00255 | 1/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.62 |
| ▸ | TSHR | P16473 | 1/20 | 0.62 |
| ▸ | HMGCR | P04035 | 4/20 | 0.59 |
| ▸ | PTPN7 | P35236 | 4/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.57 |
| ▸ | SELP | P16109 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5872593 | 1.00 | LMNA (0.62) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL5973668 | 1.00 | LMNA (0.62) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL10397636 | 1.00 | LMNA (0.62) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL8924854 | 1.00 | LMNA (0.62) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL415766 | 1.00 | LMNA (0.62) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL131748 | 1.00 | LMNA (0.62) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL4053328 | 0.98 | LMNA (0.59) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL17965716 | 0.95 | HMGCR (0.59) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL15283356 | 0.95 | HMGCR (0.59) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL4052897 | 0.95 | HMGCR (0.59) | LMNAALDH1A1HSD17B10MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1113886-C | Chemisorptive substance, aligned liquid-crystal film and liquid-crystal display element both made by using the same, and processes for producing these | MATSUSHITA ELECTRIC INDUSTRIAL CO LTD (JP) | 2003-07-09 | — | — | CN | disclosed |
| US-20030104145-A1 | Chemical adsorbent and liquid crystal alignment layer utilizing the same and liquid crystal display device utilizing the same and methods of manufacturing them | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 2003-06-05 | — | — | US | disclosed |
| US-6495221-B1 | EXTREMELY THIN AND TRANSPARENT FILM IN NANOMETER ORDER; HYDROCHALCONE DERIVATIVE SUBSTITUTED WITH A ISOCYANATOSILYL GROUP | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 2002-12-17 | — | — | US | disclosed |
| EP-0962460-A1 | CHEMISORPTIVE SUBSTANCE, ALIGNED LIQUID-CRYSTAL FILM AND LIQUID-CRYSTAL DISPLAY ELEMENT BOTH MADE BY USING THE SAME, AND PROCESSES FOR PRODUCING THESE | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 1999-12-08 | — | — | EP | disclosed |
| CN-1236368-A | Chemisorptive substance, aligned liquid-crystal film and liquid-crystal display element both made by using the same, and processes for producing these | MATSUSHITA ELECTRIC INDUSTRIAL CO LTD (JP) | 1999-11-24 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030104145-A1 | Chemical adsorbent and liquid crystal alignment layer utilizing the same and liquid crystal display device utilizing the same and methods of manufacturing them | UACA, CRYAA, CUTA | LMNA 2180/4885ALDH1A1 1972/4885HSD17B10 2987/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.